Allelic Variation of Cytochrome P450s Drives Resistance to Bednet Insecticides in a Major Malaria Vector

English version České info

Scale up of Long Lasting Insecticide Nets has massively reduced malaria mortality across Africa. However, resistance to pyrethroid insecticides in malaria vectors threatens its continued effectiveness. Here, we established that allelic variation in two CYP450s is the most important driver of pyrethroid resistance in the major African vector Anopheles funestus and detected key mutations controlling this resistance. The duplicated P450s CYP6P9a and CYP6P9b are directionally selected across Africa with alleles segregating according to resistance phenotypes. Alleles from resistant mosquitoes present significantly higher metabolic activities toward pyrethroids compared with alleles from susceptible mosquitoes. Furthermore, transgenic flies over-expressing resistant alleles of both genes were significantly more resistant to pyrethroids. Three amino acid changes from the resistant CYP6P9b allele are the key pyrethroid resistance mutations which induce high metabolic efficiency. The detection of these first DNA markers of metabolic resistance to pyrethroids allows the design of diagnostic tools to detect and track resistance.

Vyšlo v časopise: Allelic Variation of Cytochrome P450s Drives Resistance to Bednet Insecticides in a Major Malaria Vector. PLoS Genet 11(10): e32767. doi:10.1371/journal.pgen.1005618
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1005618

Souhrn

Zdroje

1. WHO. World Malaria Report 2014: World Health Organization; 2014.

2. Hemingway J. The role of vector control in stopping the transmission of malaria: threats and opportunities. Philosophical transactions of the Royal Society of London Series B, Biological sciences. 2014;369(1645):20130431. doi: 10.1098/rstb.2013.0431 24821917

3. WHO. Report of the sixteenth WHOPES working group meeting: WHO/HQ, Geneva, 22–30 July 2013: review of Pirimiphos-methyl 300 CS, Chlorfenapyr 240 SC, Deltamethrin 62.5 SC-PE, Duranet LN, Netprotect LN, Yahe LN, Spinosad 83.3 Monolayer DT, Spinosad 25 Extended release GR. Geneva, Switzerland: World Health Organization, 2013 924150630X.

4. Riveron JM, Ibrahim SS, Chanda E, Mzilahowa T, Cuamba N, Irving H, et al. The highly polymorphic CYP6M7 cytochrome P450 gene partners with the directionally selected CYP6P9a and CYP6P9b genes to expand the pyrethroid resistance front in the malaria vector Anopheles funestus in Africa. BMC Genomics. 2014;15(1):817.

5. Mulamba C, Riveron JM, Ibrahim SS, Irving H, Barnes KG, Mukwaya LG, et al. Widespread pyrethroid and DDT resistance in the major malaria vector Anopheles funestus in East Africa is driven by metabolic resistance mechanisms. PLoS One. 2014;9(10):e110058. doi: 10.1371/journal.pone.0110058 25333491

6. Coetzee M, Koekemoer LL. Molecular systematics and insecticide resistance in the major African malaria vector Anopheles funestus. Annual review of entomology. 2013;58 : 393–412. doi: 10.1146/annurev-ento-120811-153628 23317045

7. Edi CV, Djogbenou L, Jenkins AM, Regna K, Muskavitch MA, Poupardin R, et al. CYP6 P450 enzymes and ACE-1 duplication produce extreme and multiple insecticide resistance in the malaria mosquito Anopheles gambiae. PLoS Genet. 2014;10(3):e1004236. doi: 10.1371/journal.pgen.1004236 24651294

8. Ranson H, N’Guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V. Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends in parasitology. 2011;27(2):91–8. doi: 10.1016/j.pt.2010.08.004 20843745

9. WHO. Global Plan for Insecticide Resistance Management (GPIRM). Geneva, Switzerland: World Health Organization, 2012.

10. Dia I, Guelbeogo MW, Ayala D. Advances and Perspectives in the Study of the Malaria Mosquito Anopheles funestus. INTECH, 2013.

11. Dia I, Diop T, Rakotoarivony I, Kengne P, Fontenille D. Bionomics of Anopheles gambiae Giles, An. arabiensis Patton, An. funestus Giles and An. nili (Theobald) (Diptera: Culicidae) and transmission of Plasmodium falciparum in a Sudano-Guinean zone (Ngari, Senegal). Journal of medical entomology. 2003;40(3):279–83 12943105

12. Fontenille D, Lochouarn L, Diagne N, Sokhna C, Lemasson JJ, Diatta M, et al. High annual and seasonal variations in malaria transmission by anophelines and vector species composition in Dielmo, a holoendemic area in Senegal. The American journal of tropical medicine and hygiene. 1997;56(3):247–53. 9129525

13. Brooke BD, Kloke G, Hunt RH, Koekemoer LL, Temu EA, Taylor ME, et al. Bioassay and biochemical analyses of insecticide resistance in southern African Anopheles funestus (Diptera: Culicidae). Bulletin of entomological research. 2001;91(4):265–72. 11587622.

14. Casimiro SL, Hemingway J, Sharp BL, Coleman M. Monitoring the operational impact of insecticide usage for malaria control on Anopheles funestus from Mozambique. Malaria journal. 2007;6 : 142. 17973989

15. Riveron JM, Yunta C, Ibrahim SS, Djouaka R, Irving H, Menze BD, et al. A single mutation in the GSTe2 gene allows tracking of metabolically based insecticide resistance in a major malaria vector. Genome Biol. 2014;15(2):R27. doi: 10.1186/gb-2014-15-2-r27 24565444

16. Schuler MA, Berenbaum MR. Structure and function of cytochrome P450S in insect adaptation to natural and synthetic toxins: insights gained from molecular modeling. Journal of chemical ecology. 2013;39(9):1232–45. doi: 10.1007/s10886-013-0335-7 24036972

17. Riveron JM, Irving H, Ndula M, Barnes KG, Ibrahim SS, Paine MJ, et al. Directionally selected cytochrome P450 alleles are driving the spread of pyrethroid resistance in the major malaria vector Anopheles funestus. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(1):252–7. doi: 10.1073/pnas.1216705110 23248325

18. Wondji CS, Irving H, Morgan J, Lobo NF, Collins FH, Hunt RH, et al. Two duplicated P450 genes are associated with pyrethroid resistance in Anopheles funestus, a major malaria vector. Genome research. 2009;19(3):452–9. doi: 10.1101/gr.087916.108 19196725

19. Stevenson BJ, Bibby J, Pignatelli P, Muangnoicharoen S, O'Neill PM, Lian LY, et al. Cytochrome P450 6M2 from the malaria vector Anopheles gambiae metabolizes pyrethroids: Sequential metabolism of deltamethrin revealed. Insect Biochem Mol Biol. 2011;41(7):492–502. Epub 2011/02/18. doi: 10.1016/j.ibmb.2011.02.003 21324359

20. Gilbert LI, Gill SS. Insect control: biological and synthetic agents: Academic Press; 2010.

21. Bambal RB, Bloomer JC. Screening assay for inhibitors of human cytochrome P-450. Google Patents; 2006.

22. Chandor-Proust A, Bibby J, Regent-Kloeckner M, Roux J, Guittard-Crilat E, Poupardin R, et al. The central role of mosquito cytochrome P450 CYP6Zs in insecticide detoxification revealed by functional expression and structural modelling. The Biochemical journal. 2013;455(1):75–85. doi: 10.1042/BJ20130577 23844938

23. Gilbert LI, Iatrou K, Gill SS. Comprehensive molecular insect science: Elsevier; 2005.

24. BIOTOL. Molecular Fabric of Cells: Elsevier Science; 1991.

25. Schleinkofer K, Sudarko, Winn PJ, Ludemann SK, Wade RC. Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channelling? EMBO Rep. 2005;6(6):584–9. PubMed 16028306

26. Cojocaru V, Winn PJ, Wade RC. The ins and outs of cytochrome P450s. Biochimica et biophysica acta. 2007;1770(3):390–401. 16920266

27. Wade RC, Winn PJ, Schlichting I, Sudarko. A survey of active site access channels in cytochromes P450. Journal of inorganic biochemistry. 2004;98(7):1175–82. 15219983

28. Stevenson BJ, Pignatelli P, Nikou D, Paine MJ. Pinpointing P450s associated with pyrethroid metabolism in the dengue vector, Aedes aegypti: developing new tools to combat insecticide resistance. PLoS Negl Trop Dis. 2012;6(3):e1595. Epub 2012/04/06. doi: 10.1371/journal.pntd.0001595 22479665

29. Laskowski DA. Physical and chemical properties of pyrethroids. Reviews of environmental contamination and toxicology. 2002;174 : 49–170. 12132343

30. Kemp CA, Flanagan JU, van Eldik AJ, Marechal JD, Wolf CR, Roberts GC, et al. Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition. Journal of medicinal chemistry. 2004;47(22):5340–6. 15481972

31. Schlenke TA, Begun DJ. Strong selective sweep associated with a transposon insertion in Drosophila simulans. Proc Natl Acad Sci U S A. 2004;101(6):1626–31. Epub 2004/01/28. 14745026

32. Cuamba N, Morgan JC, Irving H, Steven A, Wondji CS. High level of pyrethroid resistance in an Anopheles funestus population of the Chokwe District in Mozambique. PloS one. 2010;5(6):e11010. doi: 10.1371/journal.pone.0011010 20544036

33. Pastinen T, Ge B, Hudson TJ. Influence of human genome polymorphism on gene expression. Hum Mol Genet. 2006;15 Spec No 1:R9–16. 16651375

34. Zhu F, Parthasarathy R, Bai H, Woithe K, Kaussmann M, Nauen R, et al. A brain-specific cytochrome P450 responsible for the majority of deltamethrin resistance in the QTC279 strain of Tribolium castaneum. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(19):8557–62. doi: 10.1073/pnas.1000059107 20410462

35. Daborn PJ, Lumb C, Boey A, Wong W, Ffrench-Constant RH, Batterham P. Evaluating the insecticide resistance potential of eight Drosophila melanogaster cytochrome P450 genes by transgenic over-expression. Insect biochemistry and molecular biology. 2007;37(5):512–9. 17456446

36. Amichot M, Tares S, Brun-Barale A, Arthaud L, Bride JM, Berge JB. Point mutations associated with insecticide resistance in the Drosophila cytochrome P450 Cyp6a2 enable DDT metabolism. European journal of biochemistry / FEBS. 2004;271(7):1250–7. 15030474

37. Hiroya K, Murakami Y, Shimizu T, Hatano M, Ortiz de Montellano PR. Differential roles of Glu318 and Thr319 in cytochrome P450 1A2 catalysis supported by NADPH-cytochrome P450 reductase and tert-butyl hydroperoxide. Archives of biochemistry and biophysics. 1994;310(2):397–401. 7910007

38. Morgan JC, Irving H, Okedi LM, Steven A, Wondji CS. Pyrethroid resistance in an Anopheles funestus population from Uganda. PLoS One. 2010;5(7):e11872. Epub 2010/08/06. doi: 10.1371/journal.pone.0011872 20686697

39. Djouaka R, Irving H, Tukur Z, Wondji CS. Exploring Mechanisms of Multiple Insecticide Resistance in a Population of the Malaria Vector Anopheles funestus in Benin. PLoS One. 2011;6(11):e27760. Epub 2011/11/24. doi: 10.1371/journal.pone.0027760 22110757

40. Hunt RH, Brooke BD, Pillay C, Koekemoer LL, Coetzee M. Laboratory selection for and characteristics of pyrethroid resistance in the malaria vector Anopheles funestus. Medical and veterinary entomology. 2005;19(3):271–5. 16134975

41. Hall TA, editor BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic acids symposium series; 1999.

42. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Molecular biology and evolution. 2013;30(12):2725–9. doi: 10.1093/molbev/mst197 24132122

43. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009;25(11):1451–2. doi: 10.1093/bioinformatics/btp187 19346325

44. Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. The Journal of biological chemistry. 1992;267(1):83–90. 1730627

45. Poulos TL, Finzel BC, Gunsalus IC, Wagner GC, Kraut J. The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. The Journal of biological chemistry. 1985;260(30):16122–30. 4066706

46. Sirim D, Widmann M, Wagner F, Pleiss J. Prediction and analysis of the modular structure of cytochrome P450 monooxygenases. BMC structural biology. 2010;10 : 34. doi: 10.1186/1472-6807-10-34 20950472

47. Fiser A, Sali A. Modeller: generation and refinement of homology-based protein structure models. Methods in enzymology. 2003;374 : 461–91. 14696385

48. Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF. The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. The Journal of biological chemistry. 2004;279(37):38091–4. 15258162

49. Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking. Journal of molecular biology. 1997;267(3):727–48. 9126849

50. Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of computer-aided molecular design. 1997;11(5):425–45. 9385547

51. PyMOL User's Guide [Internet]. The PyMOL Molecular Graphics System 2004

52. Petrek M, Otyepka M, Banas P, Kosinova P, Koca J, Damborsky J. CAVER: a new tool to explore routes from protein clefts, pockets and cavities. BMC bioinformatics. 2006;7 : 316. 16792811

53. Chovancova E, Pavelka A, Benes P, Strnad O, Brezovsky J, Kozlikova B, et al. CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures. PLoS computational biology. 2012;8(10):e1002708. doi: 10.1371/journal.pcbi.1002708 23093919

54. Pritchard MP, Ossetian R, Li DN, Henderson CJ, Burchell B, Wolf CR, et al. A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1. Archives of biochemistry and biophysics. 1997;345(2):342–54. 9308909

55. McLaughlin LA, Niazi U, Bibby J, David JP, Vontas J, Hemingway J, et al. Characterization of inhibitors and substrates of Anopheles gambiae CYP6Z2. Insect molecular biology. 2008;17(2):125–35. doi: 10.1111/j.1365-2583.2007.00788.x 18353102

56. Pritchard MP, McLaughlin L, Friedberg T. Establishment of functional human cytochrome P450 monooxygenase systems in Escherichia coli. Cytochrome P450 Protocols: Springer; 2006. p. 19–29.

57. Omura T, Sato R. The Carbon Monoxide-Binding Pigment of Liver Microsomes. I. Evidence for Its Hemoprotein Nature. The Journal of biological chemistry. 1964;239 : 2370–8. 14209971

58. Strobel HW, Dignam JD. Purification and properties of NADPH-cytochrome P-450 reductase. Methods in enzymology. 1978;52 : 89–96. 209290

59. Zhang R, Kang K-D, Shan G, Hammock BD. Design, synthesis and evaluation of novel P450 fluorescent probes bearing α-cyanoether. Tetrahedron letters. 2003;44(23):4331–4.

60. Lupetti A, Danesi R, Campa M, Del Tacca M, Kelly S. Molecular basis of resistance to azole antifungals. Trends in molecular medicine. 2002;8(2):76–81. 11815273

61. Kajbaf M, Longhi R, Montanari D, Vinco F, Rigo M, Fontana S, et al. A comparative study of the CYP450 inhibition potential of marketed drugs using two fluorescence based assay platforms routinely used in the pharmaceutical industry. Drug metabolism letters. 2011;5(1):30–9. 21198439

62. Zheng L, Baumann U, Reymond JL. An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic acids research. 2004;32(14):e115. 15304544

63. Li S, Wilkinson M. Site-directed mutagenesis: a two-step method using PCR and DpnI. Biotechniques. 1997;23(4):588–90. 9343667